Watson Pharmaceuticals Invests in $15M New Jersey Expansion
05/27/2010
"Over the past year, we have outgrown our current administrative headquarters site, as our U.S. and global business has rapidly grown," said Paul Biscaro, Watson president and CEO. "This new facility will ensure that we have a single location for the leadership and shared services functions that are driving our global growth."
New Jersey's Business Employment Incentive Program (BEIP) has extended Watson a grant of approximately $7.3 million over the next 10 years from the state's Economic Development Authority. It has also been approved for a $290,000 Business Retention and Relocation Assistance Grant (BRRAG) to retain 200 jobs in New Jersey.
Watson was the country's third largest producer of generic drugs in 2009 based on prescriptions dispensed. It specializes in drugs for urology and women's health.
Project Announcements
EPC-Columbia Plans Fremont, Ohio, Manufacturing Operations
11/05/2025
Aclara Resources Plans Calcasieu Parish, Louisiana, Heavy Rare Earth Separation Operations
11/04/2025
KCG Engineering Group Plans Chesapeake, Virginia, Operations
11/04/2025
Morin Establishes Little Rock, Arkansas, Operations
11/03/2025
Provalus Plans West Plains, Missouri, Operations
11/01/2025
Eos Energy Enterprises Expands Allegheny County, Pennsylvania, Operations
11/01/2025
Most Read
-
2025’s Top States for Business: How the Winners Are Outpacing the Rest
Q3 2025
-
The Compliance Reckoning Is Here
Q3 2025
-
Around the Horn: Data Center Supply Chains — What's Next?
Q3 2025
-
How Consumer Trends Are Reshaping Food Facilities
Q3 2025
-
First Person: Filter King’s Expansion Playbook
Q3 2025
-
Rethinking Auto Site Strategy in the Age of Tariffs and Powertrain Shifts
Q3 2025
-
Lead with Facts, Land the Deal
Q3 2025